Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ · Healthcare
Kiniksa Pharmaceuticals International, plc Cash on Hand 2021–2025
Kiniksa Pharmaceuticals International, plc annual cash on hand history from 2021 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Kiniksa Pharmaceuticals International, plc cash on hand as of December 31, 2025: 165.6M, a 9.80% decrease year-over-year.
- Kiniksa Pharmaceuticals International, plc cash on hand for 2025 were 165.6M, a 9.80% decrease from 2024.
- Kiniksa Pharmaceuticals International, plc cash on hand for 2024 were 183.6M, a 70.05% increase from 2023.
- Kiniksa Pharmaceuticals International, plc cash on hand for 2023 were 108.0M, a 12.03% decrease from 2022.
- Kiniksa Pharmaceuticals International, plc cash on hand for 2022 were 122.7M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Kiniksa Pharmaceuticals International, plc Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $166 |
| 2024 | $184 |
| 2023 | $108 |
| 2022 | $123 |
| 2021 | $122 |
Kiniksa Pharmaceuticals International, plc Cash on Hand — FAQ
Kiniksa Pharmaceuticals International, plc (KNSA) cash on hand over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KNSA's cash on hand history?
The chart and table above show Kiniksa Pharmaceuticals International, plc's cash on hand by year and by quarter, including the growth rate.